SCHEMBL10522729

SCHEMBL10522729

CCOC(=O)[C@H](CSC1Cc2ccccc2C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)OC

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 14/20 0.57
▸ LMNA P02545 2/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ ABCB11 O95342 2/20 0.51
▸ PDE3A Q14432 1/20 0.44
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10522707 1.00 ACE (0.57) ACELMNASMN1; SMN2ABCB11PDE3A
SCHEMBL10522603 0.93 ACE (0.56) ACELMNASMN1; SMN2ABCB11PDE3A
SCHEMBL10522600 0.93 ACE (0.56) ACELMNASMN1; SMN2ABCB11PDE3A
SCHEMBL10523907 0.87 ACE (0.52) ACELMNASMN1; SMN2ABCB11MEN1
SCHEMBL10523915 0.87 ACE (0.52) ACELMNASMN1; SMN2ABCB11MEN1
SCHEMBL10523157 0.86 ACE (0.52) ACELMNASMN1; SMN2ABCB11MEN1
SCHEMBL10523169 0.86 ACE (0.52) ACELMNASMN1; SMN2ABCB11MEN1
SCHEMBL10521713 0.82 ACE (0.64) ACELMNASMN1; SMN2ABCB11
SCHEMBL10521734 0.82 ACE (0.64) ACELMNASMN1; SMN2ABCB11
SCHEMBL16364868 0.81 ACE (0.85) ACELMNASMN1; SMN2ABCB11PDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4886813-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1989-12-12 — — US claimed
US-4886813-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1989-12-12 — — US disclosed
Send feedback